Nephrolithiasis and Nephrocalcinosis Panel
New York
Approved
Genes
Conditions
- Distal Renal Tubular Acidosis
- Bartter Syndrome
- Xanthinuria
- APRT Deficiency
- Cystinuria
- Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis
- Hypophosphatasia
- Idiopathic Infantile Hypercalcemia
- Nephrocalcinosis
- Nephrolithiasis
- Primary Hyperoxaluria
- Renal Hypouricemia
- CA II Deficiency
- Dent Disease
- Familial Hypocalciuric Hypercalcemia (FHH)
- Hypophosphatemic nephrolithiasis/osteoporosis
- Hypophosphatemic rickets
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Development of appropriate evaluation and management plan
- Testing of at-risk relatives for specific known variant(s) previously identified in an affected family member
- Genetic counseling and recurrence risk assessment
Lab Method
- Next-Gen Sequencing
- Deletion/Duplication Analysis
Test Code
TH01
CPT Codes*
81404x2, 81405x1, 81406x2, 81407x1, 81479x3
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing